Alternative pharmacological treatment options for agitation in Alzheimer’s disease

Alternative pharmacological treatment options for agitation in Alzheimer’s disease

In patients with dementia and Alzheimer’s disease (AD), treatment of neuropsychiatric symptoms (NPS) is a major concern in the management of these devastating diseases. Among NPS in AD, agitation and aggression are common with earlier institutionalization, increased morbidity and mortality, and grea...

Full description

Bibliographic Details
Main Authors:	Francesco Panza, Vincenzo Solfrizzi, Bruno P. Imbimbo, Andrea Santamato, Madia Lozupone, Giancarlo Logroscino
Format:	Article
Language:	English
Published:	PAGEPress Publications 2015-11-01
Series:	Geriatric Care
Subjects:	Agitation aggression Alzheimer’s disease dementia antipsychotics antidepressants.
Online Access:	http://www.pagepressjournals.org/index.php/gc/article/view/5460

Similar Items

A reflection on the use of Antidepressants to manage agitation in dementia
by: M.D.R.D.R.F.D. Basto, et al.
Published: (2022-06-01)

Clinical Trial Studies of Antipsychotics during Symptomatic Presentations of Agitation and/or Psychosis in Alzheimer’s Dementia: A Systematic Review
by: Haider Qasim, et al.
Published: (2023-06-01)

Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis
by: Kaili Chen, et al.
Published: (2023-03-01)

Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis
by: Yi-Ting Lin, et al.
Published: (2015-02-01)

Electroconvulsive in a 75-year-old patient with severe agitated behavior and dementia
by: Harshal Sathe, et al.
Published: (2017-01-01)

A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)
by: Haider Saddam Qasim, et al.
Published: (2022-06-01)

Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer’s Disease and Related Dementias
by: William D. Todd
Published: (2020-09-01)

Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trials
by: Kathy Y. Liu, et al.
Published: (2021-01-01)

Managing acute agitation and aggression in the world of drug shortages
by: Jennifer Miller, PharmD, BCPP
Published: (2021-11-01)

Barriers and facilitators to care for agitation and/or aggression among persons living with dementia in long-term care
by: Britney Wong, et al.
Published: (2024-04-01)

Relationship between the severity of agitation and quality of life in residents with dementia living in German nursing homes - a secondary data analysis
by: Kathrin Schmüdderich, et al.
Published: (2021-04-01)

Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals
by: Alok Joshi, et al.
Published: (2022-10-01)

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
by: Claudia Carrarini, et al.
Published: (2021-04-01)

The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
by: Michael P. Wilson, et al.
Published: (2012-04-01)

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
by: Sube Banerjee, et al.
Published: (2023-10-01)

The agitated pediatric patient located in the emergency department: The APPLIED observational study
by: Matthias M. Manuel, et al.
Published: (2022-06-01)

Brazilian guidelines for the management of psychomotor agitation. Part 2. Pharmacological approach
by: Leonardo Baldaçara, et al.
Published: (2019-03-01)

Wrist accelerometry for monitoring dementia agitation behaviour in clinical settings: A scoping review
by: James Chung-Wai Cheung, et al.
Published: (2022-09-01)

Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting
by: Scott L. Zeller, MD, et al.
Published: (2016-03-01)

The comparative efficacy of Haloperidol (IM) plus Lorazepam (PO) and Risperidon plus Lorazepam in the management of acute agitation
by: H.Toofanei (M.D), et al.
Published: (2002-09-01)

Psychotropic drug use and mortality in old people with dementia: investigating sex differences
by: Jon Brännström, et al.
Published: (2017-05-01)

Care partner evaluation of the behaviors in the Cohen-Mansfield Agitation Inventory
by: Dorothee Oberdhan, et al.
Published: (2024-03-01)

Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)

Effect of Head and Face Massage on Agitation in Elderly Alzheimer's Disease Patients
by: Saeid Keshavarz, et al.
Published: (2018-01-01)

The Impact of Individualized Music Therapy on the Behavior of Agitation in Elderly Patients with Alzheimer Living in Nursing Homes
by: Sara Aghdamizade, et al.
Published: (2016-08-01)

The Impact of Individualized Music Therapy on the Behavior of Agitation in Elderly Patients with Alzheimer Living in Nursing Homes
by: Sarah Aghdamizaheh, et al.
Published: (2016-07-01)

Measuring Electrodermal Activity to Improve the Identification of Agitation in Individuals with Dementia
by: Catharina Melander, et al.
Published: (2017-12-01)

Nutrition, Frailty, and Alzheimer's Disease
by: Francesco ePanza, et al.
Published: (2014-08-01)

A Critical Review of the Psychomotor Agitation Treatment in Youth
by: Beniamino Tripodi, et al.
Published: (2023-01-01)

The Impact of Apolipoprotein E (<i>APOE</i>) Epigenetics on Aging and Sporadic Alzheimer’s Disease
by: Madia Lozupone, et al.
Published: (2023-12-01)

Alternatives to the Use of Mechanical Restraints in the Management of Agitation or Aggressions of Psychiatric Patients: A Scoping Review
by: Damián Fernández-Costa, et al.
Published: (2020-08-01)

Psychotropic prescribing for English care home residents with dementia compared with national guidance: findings from the MARQUE national longitudinal study
by: Francesca La Frenais, et al.
Published: (2021-09-01)

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
by: Faden J, et al.
Published: (2019-08-01)

Effects of Music on Agitation in Dementia: A Meta-Analysis
by: Siv K. A. Pedersen, et al.
Published: (2017-05-01)

Risk factors for agitation in home-cared older adults with dementia: evidence from 640 elders in East China
by: Jiaxin Liu, et al.
Published: (2023-07-01)

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder
by: Citrome L, et al.
Published: (2017-12-01)

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
by: Yalin N, et al.
Published: (2020-06-01)

Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) Pain Scale: Study Protocol
by: Damiana Scuteri, et al.
Published: (2022-04-01)

Pharmacological management of behavioral and psychological symptoms of dementia: Brief review
by: Shobit Garg, et al.
Published: (2022-01-01)

Different types of akathisia: clinical analysis on three cases
by: Lei WANG, et al.
Published: (2018-09-01)